Gael Forterre - Oct 4, 2023 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Role
Chief Commercial Officer
Signature
/s/ Gael Forterre
Stock symbol
VNRX
Transactions as of
Oct 4, 2023
Transactions value $
-$3,731
Form type
4
Date filed
10/6/2023, 04:05 PM
Previous filing
Aug 7, 2023
Next filing
Jan 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VNRX Common Stock Tax liability -$3.73K -5.53K -5.13% $0.68 102K Oct 4, 2023 Direct F1
holding VNRX Common Stock 5K Oct 4, 2023 By Spouse
holding VNRX Common Stock 32.5K Oct 4, 2023 By Armori Capital Management, LLC F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 15,334 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.
F2 These shares of common stock are managed by Armori Capital Management, LLC ("Armori Capital"). Mr. Forterre is the managing director and sole shareholder of Armori Capital and has voting and dispositive control over the shares held by Armori Capital. Mr. Forterre disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.